Lynn M. Bodarky

Corporate Officer/Principal presso ACTINIUM PHARMACEUTICALS, INC.

58 anni

Health Technology

Consumer Services

Profilo

Lynn M.
Bodarky is currently the Chief Business Officer at Actinium Pharmaceuticals, Inc. Previously, she was the Vice President of Business Development at Geron Corp.
from 2019 to 2021 and the Vice President of Marketing at Progenics Pharmaceuticals, Inc. from 2004 to 2007.
She also held the position of Senior VP & Global Head of Business Development at HiFiBiO Inc. Ms. Bodarky has an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Wharton School of the University of Pennsylvania.

Posizioni attive di Lynn M. Bodarky

Società	Posizione	Inizio
ACTINIUM PHARMACEUTICALS, INC.	Corporate Officer/Principal	03/11/2023

Tutte le posizioni attive di Lynn M. Bodarky

Precedenti posizioni note di Lynn M. Bodarky

Società	Posizione	Fine
GERON CORPORATION	Corporate Officer/Principal	01/01/2021
PROGENICS PHARMACEUTICALS, INC.	Vendite & Marketing	01/01/2007
HiFiBiO Inc. HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Lynn M. Bodarky

Formazione di Lynn M. Bodarky

The Trustees of Columbia University in The City of New York	Masters Business Admin
The Wharton School of the University of Pennsylvania	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Lynn M. Bodarky

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
GERON CORPORATION	Health Technology
ACTINIUM PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Progenics Pharmaceuticals, Inc. Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY.	Health Technology
HiFiBiO Inc. HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France.	Health Technology